Evolva Holding S.A.
Evolva Holding S.A. (EVE.SW) Stock Overview
Explore Evolva Holding S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
8M
P/E Ratio
9.28
EPS (TTM)
$0.14
ROE
0.13%
EVE.SW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Evolva Holding S.A. (EVE.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.17, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.48.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.28 and a market capitalization of 8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Gerhard Lobmaier
49
Duggingerstrasse 23, Reinach
2005